A share price of Idexx Laboratories, Inc [IDXX] is currently trading at $682.78, up 27.49%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IDXX shares have gain 20.53% over the last week, with a monthly amount glided 24.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Idexx Laboratories, Inc [NASDAQ: IDXX] stock has seen the most recent analyst activity on July 01, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $625. Previously, Leerink Partners started tracking the stock with Outperform rating on December 02, 2024, and set its price target to $500. On July 25, 2024, BTIG Research initiated with a Buy rating and assigned a price target of $580 on the stock. Piper Sandler downgraded its rating to a Neutral but stick to its price target of $525 on January 30, 2024. Exane BNP Paribas initiated its recommendation with a Outperform and recommended $602 as its price target on December 07, 2023. Cleveland Research upgraded its rating to Buy for this stock on December 04, 2023. In a note dated August 02, 2023, Atlantic Equities downgraded an Neutral rating on this stock but restated the target price of $610.
Idexx Laboratories, Inc experienced fluctuations in its stock price throughout the past year between $356.14 and $579.47. Currently, Wall Street analysts expect the stock to reach $479.75 within the next 12 months. Idexx Laboratories, Inc [NASDAQ: IDXX] shares were valued at $682.78 at the most recent close of the market. An investor can expect a potential drop of -29.74% based on the average IDXX price forecast.
Analyzing the IDXX fundamentals
Trailing Twelve Months sales for Idexx Laboratories, Inc [NASDAQ:IDXX] were 4.04B which represents 10.55% growth. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.28, Equity is 0.57 and Total Capital is 0.55. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Idexx Laboratories, Inc [NASDAQ:IDXX] is 1.11. Further, the Quick Ratio stands at 0.79, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 13.60, the price to book ratio is 38.07 and price to earnings (TTM) ratio is 56.83.
Transactions by insiders
Recent insider trading involved SZOSTAK M ANNE, Director, that happened on May 21 ’25 when 1260.0 shares were sold. Director, SZOSTAK M ANNE completed a deal on May 21 ’25 to sell 1046.0 shares. Meanwhile, Director SZOSTAK M ANNE bought 1260.0 shares on May 21 ’25.
